Compounds > ic 831423

Page last updated: 2024-09-04

ic 831423 and Blood Clot

ic 831423 has been researched along with Blood Clot in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	1 (11.11)	18.2507
2000's	5 (55.56)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coghlan, DW; Gallus, AS	1
Bick, RL; Fareed, J; Hoppensteadt, D; Walenga, JM	1
Mousa, SA	1
Fareed, J; Hoppensteadt, D; Jeske, WP; Walenga, JM	1
Bick, RL; Fareed, J; Frenkel, EP; Hoppensteadt, DA; Walenga, J	1
Bara, L; Fareed, J; Jeske, WP; Samama, MM; Walenga, JM	1
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM	1
Choay, J; Fareed, J; Lormeau, JC; Petitou, M; Samama, M; Walenga, JM	2

Reviews

6 review(s) available for ic 831423 and Blood Clot

Article	Year
Heparin pentasaccharide. Current opinion in hematology, 2002, Volume: 9, Issue:5 Topics: Animals; Clinical Trials as Topic; Fondaparinux; Heparin; Humans; Oligosaccharides; Orthopedic Procedures; Polysaccharides; Thrombosis	2002
Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation. Hematology/oncology clinics of North America, 2003, Volume: 17, Issue:1 Topics: Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Thrombosis	2003
Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases. Methods in molecular medicine, 2004, Volume: 93 Topics: Heparin; Heparin, Low-Molecular-Weight; Humans; Inflammation; Neoplasms; Oligosaccharides; Thrombosis	2004
Factor Xa inhibitors. Methods in molecular medicine, 2004, Volume: 93 Topics: Animals; Anticoagulants; Factor Xa Inhibitors; Heparin; Humans; In Vitro Techniques; Invertebrate Hormones; Lipoproteins; Naphthalenes; Oligosaccharides; Propionates; Recurrence; Thrombosis	2004
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. Hematology/oncology clinics of North America, 2005, Volume: 19, Issue:1 Topics: Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Pharmacokinetics; Polysaccharides; Thrombosis; Treatment Outcome	2005
Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide. Thrombosis research, 1997, Apr-01, Volume: 86, Issue:1 Topics: Animals; Anticoagulants; Antithrombin III; Binding Sites; Blood Platelets; Carbohydrate Sequence; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; In Vitro Techniques; Molecular Sequence Data; Molecular Structure; Oligosaccharides; Thrombosis	1997

Other Studies

3 other study(ies) available for ic 831423 and Blood Clot

Article	Year
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thrombosis research, 1989, Jun-01, Volume: 54, Issue:5 Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K	1989
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges. Thrombosis research, 1987, Apr-15, Volume: 46, Issue:2 Topics: Animals; Antithrombin III; Disease Models, Animal; Dose-Response Relationship, Drug; Factor X; Factor Xa; Heparin; Male; Oligosaccharides; Prothrombin; Rabbits; Thromboplastin; Thrombosis	1987
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model. Thrombosis research, 1986, Jul-15, Volume: 43, Issue:2 Topics: Animals; Disease Models, Animal; Factor X; Factor Xa; Heparin; Humans; Injections, Intravenous; Male; Oligosaccharides; Prothrombin; Rabbits; Thrombin; Thrombosis	1986